Breathe Well-being raises $5.5 mn in Series A round led by Accel

This round saw the exit of angel investors who have received a 30X exit and early employees being rewarded with ESOPs encashment

Digital therapeutics company Breathe Well-being that helps people prevent, manage and reverse Type 2 Diabetes has raised $5.5 million in Series A led by Accel. The round saw participation from marquee investors like General Catalyst and Scott Shleifer, Global MD, Tiger Global.

This round saw exit of angel invstors who have received a 30X exit and early employees being rewarded with ESOPs encashment. The company will invest the funds raised to scale up the tech platform and team expansion.

“Our mission is to help 1 million Indians reverse Type 2 Diabetes by 2025. We are focusing on enhancing patient experience